CohBar, Inc. – NASDAQ:CWBR

Add to watchlist

Market closed

Open in about 10 hours

+120.00%

month

+120.00%

quarter

-27.32%

year

Market Cap	1.57M
Enterprise value	N/A

P/E	-0.39
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	0.30
PEG ratio	N/A
EPS	-4.26

Revenue	N/A
EBITDA	-12.58M
Income	-12.34M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

CohBar, Inc. (NASDAQ:CWBR): Profit margin
Sep 2022	0	-2.31M
Dec 2022	0	-3.67M
Mar 2023	0	-2.03M
Jun 2023	0	-4.33M

CohBar Financials Estimate

Q Y

CohBar, Inc. (NASDAQ:CWBR): Analyst Estimates
2025	0	-30.45M

Analysts Price target
Financials & Ratios estimates

CohBar, Inc. (NASDAQ:CWBR): Debt to assets
Sep 2022	19292616	546.49K	2.83%
Dec 2022	16365667	1.03M	6.32%
Mar 2023	14402320	898.54K	6.24%
Jun 2023	12506093	3.00M	24%

CohBar, Inc. (NASDAQ:CWBR): Cash Flow
Sep 2022	-1.78M	3.08M	34.87K
Dec 2022	-2.72M	4.44M	1
Mar 2023	-1.62M	1.08M	0
Jun 2023	-1.80M	2.60M	0

CohBar alternative data

CohBar, Inc. (NASDAQ:CWBR): Employee count
Aug 2023	9
Sep 2023	9
Oct 2023	9
Nov 2023	9
Dec 2023	9
Jan 2024	9
Feb 2024	9
Mar 2024	9
Apr 2024	9
May 2024	9
Jun 2024	9
Jul 2024	9

CohBar
Hedge Funds Holdings Q1 2023

0.90% -3.93%

of CWBR is owned by hedge funds

13 -4

hedge funds hold CWBR stock

26.01K -114.03K

shares is hold by hedge funds

CWBR hedge funds holdings changes

CohBar, Inc. (NASDAQ:CWBR): Insider trades (number of shares)
Period	Buy	Sel
Dec 2020	187865	0
Feb 2021	0	10000
Aug 2021	20000	10000
Oct 2021	167000	0
Nov 2021	67778	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	1 Nov 2021	BARZILAI NIR YACOV director director	Common Stock Warrants (Right to buy)	13,889	$0.72	$10,000
Purchase	1 Nov 2021	BARZILAI NIR YACOV director director	Common Stock	13,889	N/A	N/A
Purchase	1 Nov 2021	GREENWOOD DAVID director director	Common Stock Warrants (Right to buy)	20,000	$0.72	$14,400
Purchase	1 Nov 2021	GREENWOOD DAVID director director	Common Stock	20,000	N/A	N/A
Purchase	28 Oct 2021	PETKEVICH MISHA director director	Common Stock	167,000	$0.58	$96,192
Purchase	18 Aug 2021	SARRET JOSEPH J.	Common Stock	20,000	$1.12	$22,400
Option	11 Aug 2021	CUNDY KENNETH C officer: Chief Sc..	Common Stock	10,000	$0.73	$7,300
Sale	11 Aug 2021	CUNDY KENNETH C officer: Chief Sc..	Common Stock	10,000	$0.73	$7,300
Option	11 Aug 2021	CUNDY KENNETH C officer: Chief Sc..	Stock Option (right to buy)	10,000	$0.73	$7,300
Option	16 Feb 2021	CUNDY KENNETH C officer: Chief Sc..	Common Stock	10,000	$0.73	$7,300

Status	Patent	Filling date	Issue date
Application	Application THERAPEUTIC PEPTIDES Filling date: 11 Apr 2022 Issue date: 4 Aug 2022	11 Apr 2022	4 Aug 2022
Application	Application THERAPEUTIC PEPTIDES Filling date: 28 Jan 2020 Issue date: 21 Jul 2022	28 Jan 2020	21 Jul 2022
Grant	Grant Utility: Therapeutic peptides Filling date: 4 Aug 2021 Issue date: 17 May 2022	4 Aug 2021	17 May 2022
Application	Application THERAPEUTIC PEPTIDES Filling date: 4 Aug 2021 Issue date: 25 Nov 2021	4 Aug 2021	25 Nov 2021
Grant	Grant Utility: Therapeutic peptides Filling date: 27 Sep 2017 Issue date: 7 Sep 2021	27 Sep 2017	7 Sep 2021
Application	Application PEPTIDE-CONTAINING FORMULATIONS Filling date: 27 Mar 2019 Issue date: 4 Feb 2021	27 Mar 2019	4 Feb 2021
Application	Application THERAPEUTIC PEPTIDES Filling date: 27 Sep 2017 Issue date: 11 Jun 2020	27 Sep 2017	11 Jun 2020

CohBar
Earnings Call Transcripts

Quarter	Transcript
Q3 2022 11 Nov 2022	Q3 2022 Earnings Call Transcript
Q2 2022 15 Aug 2022	Q2 2022 Earnings Call Transcript
Q1 2022 16 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 29 Mar 2022	Q4 2021 Earnings Call Transcript

CWBR earnings call transcripts

CohBar
Executives

Insider	Age	Since	Compensation
Dr. Kenneth C. Cundy (1959) Chief Scientific Officer	66		$463,550
Mr. Jeffrey F. Biunno CPA, M.B.A., CPA, MBA (1966) Chief Financial Officer, Treasurer & Sec.	59		$387,500

CohBar
Latest News

Monday, 27 November 2023
18:05	CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)	businesswire.com
Tuesday, 19 September 2023
13:57	COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR	businesswire.com
Monday, 14 August 2023
16:01	CohBar Reports Second Quarter 2023 Financial Results	globenewswire.com
Tuesday, 23 May 2023
11:44	Why Is CohBar (CWBR) Stock Up 130% Today?	InvestorPlace
Wednesday, 26 October 2022
09:00	CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022	GlobeNewsWire
Friday, 21 October 2022
13:33	Cohbar Inc. (CWBR) Upgraded to Strong Buy: What Does It Mean for the Stock?	Zacks Investment Research
Monday, 26 September 2022
18:21	7 Nasdaq Stocks to Sell Before They Die	InvestorPlace
Friday, 23 September 2022
08:35	CohBar (CWBR) Stock: 1-For-30 Reverse Split Goes Into Effect	Pulse2
Tuesday, 6 September 2022
09:00	CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference	GlobeNewsWire
Monday, 15 August 2022
20:11	CohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call Transcript	Seeking Alpha
Monday, 1 August 2022
09:00	CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022	GlobeNewsWire
Thursday, 19 May 2022
16:02	CohBar to Present at the H.C. Wainwright Global Investment Conference	GlobeNewsWire
Monday, 16 May 2022
21:20	CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Monday, 2 May 2022
09:00	CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022	GlobeNewsWire
Tuesday, 29 March 2022
22:44	CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 15 March 2022
09:00	CohBar to Announce 2021 Fourth Quarter and Full-Year Financial Results and Provide Business Update on March 29, 2022	GlobeNewsWire
Monday, 3 January 2022
09:00	CohBar to Present at H.C. Wainwright BIOCONNECT Conference	GlobeNewsWire
Friday, 31 December 2021
11:22	7 of the Best Penny Stocks Under $3 for 2022 to Buy Now	InvestorPlace
Monday, 15 November 2021
21:43	CohBar, Inc. (CWBR) CEO Joe Sarret on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
Monday, 1 November 2021
15:23	5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes	PennyStocks
09:00	CohBar to Announce 2021 Third Quarter Financial Results and Provide Business Update on November 15, 2021	GlobeNewsWire
Wednesday, 13 October 2021
09:00	CohBar Announces CB4211 Phase 1a/1b Results Selected for Late Breaker Presentation at The Liver Meeting® 2021	GlobeNewsWire
Wednesday, 15 September 2021
09:00	CohBar Appoints Joanne Yun, Ph.D. to Its Board of Directors	GlobeNewsWire
Wednesday, 8 September 2021
09:00	CohBar Granted U.S. Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)	GlobeNewsWire
Monday, 16 August 2021
09:00	CohBar Appoints Carol Nast to Its Board of Directors	GlobeNewsWire

Ideas & Opinions

Seeking Alpha 23 Apr 2021

CohBar: A Promising Early Pureplay On Mitochondrial-Based Therapeutics

Frequently Asked Questions (FAQ)

When is CohBar's next earnings date?

Unfortunately, CohBar's (CWBR) next earnings date is currently unknown.
Does CohBar pay dividends?

No, CohBar does not pay dividends.
How much money does CohBar make?

CohBar has a market capitalization of 1.57M.
What is CohBar's stock symbol?

CohBar, Inc. is traded on the NASDAQ under the ticker symbol "CWBR".
What is CohBar's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of CohBar?

Shares of CohBar can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are CohBar's key executives?
CohBar's management team includes the following people:
- Dr. Kenneth C. Cundy Chief Scientific Officer(age: 66, pay: $463,550)
- Mr. Jeffrey F. Biunno CPA, M.B.A., CPA, MBA Chief Financial Officer, Treasurer & Sec.(age: 59, pay: $387,500)
How many employees does CohBar have?

As Jul 2024, CohBar employs 9 workers.
When CohBar went public?

CohBar, Inc. is publicly traded company for more then 7 years since IPO on 15 Dec 2017.
What is CohBar's official website?

The official website for CohBar is cohbar.com.
Where are CohBar's headquarters?

CohBar is headquartered at 1455 Adams Drive, Menlo Park, CA.
How can i contact CohBar?

CohBar's mailing address is 1455 Adams Drive, Menlo Park, CA and company can be reached via phone at +65 04467888.

CohBar, Inc.

cohbar.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.

+65 04467888

1455 Adams Drive
Menlo Park, CA 94025

CIK: 0001522602
ISIN: US19249J3077
CUSIP: 19249J109